WNT10B and type 1 diabetes mellitus: Moreover, the expression of Wnt10b is inhibited in bone of mice with T1DM, and elevation of TNF‐α is found to be a critical factor leading to its down‐regulation and bone loss in diabetic environment; thus, overexpression of Wnt10b in bone has a potential utility for the treatment of bone loss in diabetic patients.127